What is preventing the use of high path avian flu vaccines?

High path avian influenza has affected close to 170 million birds over the past three years.

USDA is working to combat the virus and lower egg prices through a new strategy, which includes funding for vaccine research.

American Farm Bureau Economist Bernt Nelson spoke with RFD-TV’s Suzanne Alexander about current HPAI vaccines and what is preventing the use of them.

Related Stories
A smaller U.S. turkey flock and resurgent avian flu have tightened supplies, driving prices higher even as other key holiday foods show mixed trends.
Highly Pathogenic Avian Flu (HPAI) cases are rising. In the last week, seven commercial turkey, duck, and egg layer flocks were culled across five Midwest states and California.
While there has been an increase in outbreaks of Highly Pathogenic Avian Influenza (HPAI) this migration season, the CDC says the public health risk is low.
Approximately 42,000 birds were affected in the outbreak, officials said.
AFBF Economist Bearnt Nelson joins us with insights into current turkey flock sizes, HPAI concerns, and production impacts on holiday demand.
Bird owners are urged to practice strong biosecurity as fall brings a rise in high path avian flu cases.
China is making strategic moves by purchasing more soybeans from Argentina and may soon follow the EU and reopen its market to Brazilian chicken exports.
Farmers may benefit from higher turkey prices this holiday season, but risks from HPAI and limited poult placements could further strain the supply.